共 50 条
- [21] Ubrogepant for the Acute Treatment of Migraine: Pooled Safety and Tolerability from ACHIEVE I and ACHIEVE II Phase 3 StudiesHEADACHE, 2019, 59 : 120 - 120Hutchinson, S.Dodick, D. W.Treppendahl, C.Bennett, N. L.Yu, S.Guo, H.Trugman, J. M.
- [22] Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials (vol 34, pg 1327, 2017)ADVANCES IN THERAPY, 2017, 34 (07) : 1772 - 1772Adsit, SandraZaldivar, Enrique RivasSofen, HowardDei-Cas, IgnacioMaldonado-Garcia, CesarPenaranda, Elkin O.Puig, LuisMeng, XiangyiFox, ToddGuana, Adriana
- [23] Pooled Analysis of Safety and Tolerability with Fremanezumab Treatment in Patients with Migraine and Baseline Cardiovascular Medication or Concomitant Triptan UseANNALS OF NEUROLOGY, 2020, 88 : S155 - S155Coppola, GianlucaNing, XiaopingKessler, YoelCohen, Joshua M.Du, EvelynBarbanti, Piero
- [24] POOLED ANALYSIS OF CARDIOVASCULAR SAFETY WITH FREMANEZUMAB TREATMENT IN PATIENTS WITH MIGRAINE AND CONCOMITANT CARDIOVASCULAR MEDICATION OR TRIPTAN USE AT BASELINECEPHALALGIA, 2020, 40 : 83 - 83Coppola, GianlucaNing, XiaopingKessler, YoelCohen, Joshua M.Du, EvelynBarbanti, Piero
- [25] Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trialsEPILEPSIA, 2022, 63 (08) : 2024 - 2036Ryvlin, PhilippeDimova, SvetlanaElmoufti, SamiFloricel, FlorinLaloyaux, CedricNondonfaz, XavierBiton, Victor
- [26] Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trialsJOURNAL OF HEADACHE AND PAIN, 2019, 20 (1): : 84Loo, Li ShenAilani, JessicaSchim, JackBaygani, SiminHundemer, Hans-PeterPort, MarthaKrege, John H.
- [27] Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trialsThe Journal of Headache and Pain, 2019, 20Li Shen LooJessica AilaniJack SchimSimin BayganiHans-Peter HundemerMartha PortJohn H. Krege
- [28] Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trialsJOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):Rizzoli, PaulMarmura, Michael J.Robblee, JenniferMcvige, JenniferSacco, SaraNahas, Stephanie J.Ailani, JessicaDe Abreu Ferreira, RosaMa, JuliaSmith, Jonathan H.Dabruzzo, BrettAshina, Messoud
- [29] Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trialsThe Journal of Headache and Pain, 25Paul RizzoliMichael J. MarmuraJennifer RobbleeJennifer McVigeSara SaccoStephanie J. NahasJessica AilaniRosa De Abreu FerreiraJulia MaJonathan H. SmithBrett DabruzzoMessoud Ashina
- [30] Early Improvements With Atogepant for the Preventive Treatment of Migraine: Results From 3 Randomized Phase 3 TrialsNEUROLOGY, 2025, 104 (02)Lipton, Richard B.Gandhi, PranavTassorelli, CristinaReuter, UweHarriott, Andrea M.Holle-Lee, DagnyGottschalk, Christopher H.Neel, BrianLiu, YingyiGuo, HuaStokes, JonathanNagy, KrisztianDabruzzo, BrettSmith, Jonathan H.